NYSE:MRSH Marsh & McLennan Companies (MRSH) Stock Price, News & Analysis $190.61 -0.65 (-0.34%) Closing price 10/21/2026 03:59 PM EasternExtended Trading$190.66 +0.05 (+0.03%) As of 06:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Marsh & McLennan Companies Stock (NYSE:MRSH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MRSH alerts:Sign Up Key Stats Today's Range$189.16▼$191.9850-Day Range$168.97▼$194.6152-Week Range$156.60▼$198.49Volume1.71 million shsAverage Volume2.75 million shsMarket Capitalization$90.64 billionP/E Ratio22.80Dividend Yield2.08%Price Target$204.42Consensus RatingHold Company Overview Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management. Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions. Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world. John Doyle serves as president and chief executive officer. The company is headquartered in New York City.AI Generated. May Contain Errors. Read More Marsh & McLennan Companies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreMRSH MarketRank™: 4.47003070351 of 5 starsMarsh & McLennan Companies scored higher than 89% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingHold Consensus RatingMarsh & McLennan Companies has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 2 strong buy ratings, 6 buy ratings, 11 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for Marsh & McLennan Companies is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageMarsh & McLennan Companies has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Marsh & McLennan Companies' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.99% Earnings GrowthEarnings for Marsh & McLennan Companies are expected to grow by 8.99% in the coming year, from $10.46 to $11.40 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Marsh & McLennan Companies is 22.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 36.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Marsh & McLennan Companies is 22.80, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.15.Price to Earnings Growth RatioMarsh & McLennan Companies has a PEG Ratio of 2.65. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMarsh & McLennan Companies has a P/B Ratio of 6.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.34% of the float of Marsh & McLennan Companies has been sold short.Short Interest Ratio / Days to CoverMarsh & McLennan Companies has a short interest ratio ("days to cover") of 1.87, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Marsh & McLennan Companies has recently increased by 8.18%, indicating that investor sentiment is decreasing significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldMarsh & McLennan Companies pays a meaningful dividend of 2.10%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMarsh & McLennan Companies has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Marsh & McLennan Companies is 47.37%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Marsh & McLennan Companies will have a dividend payout ratio of 34.74% next year. This indicates that Marsh & McLennan Companies will be able to sustain or increase its dividend.Read more about Marsh & McLennan Companies' dividend. News and Social Media3.6 / 5News Sentiment0.78 News SentimentMarsh & McLennan Companies has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 54 news articles for Marsh & McLennan Companies this week, compared to 8 articles on an average week.Search InterestOnly 3 people have searched for MRSH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows6 people have added Marsh & McLennan Companies to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Marsh & McLennan Companies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,597,903.00 in company stock.Percentage Held by Insiders0.38% of the stock of Marsh & McLennan Companies is held by insiders.Percentage Held by Institutions87.99% of the stock of Marsh & McLennan Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Marsh & McLennan Companies' insider trading history. Receive MRSH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Marsh & McLennan Companies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRSH Stock News HeadlinesJPMorgan Chase & Co. Forecasts Strong Price Appreciation for Marsh & McLennan Companies (NYSE:MRSH) Stock4 hours ago | americanbankingnews.comMarsh & McLennan Companies (MRSH) Retained on Investment Bench Following Full Position ExitOctober 21 at 9:35 AM | finance.yahoo.comMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden. One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency, has just cleared an important FDA milestone.October 22 at 1:00 AM | Market Tactic (Ad)Marsh & McLennan Companies (NYSE:MRSH) Stock Price Expected to Rise, Mizuho Analyst SaysOctober 21 at 2:22 AM | americanbankingnews.comMarsh & McLennan Companies (NYSE:MRSH) Stock Gets Price Target Boost from Keefe, Bruyette & WoodsOctober 21 at 1:42 AM | americanbankingnews.comMarsh & McLennan : Global commercial insurance rates fall 5% in Q3 2026; marks ninth consecutive quarterly declineOctober 20 at 12:59 AM | marketscreener.comMAging Populations Are Straining Retirement Systems Worldwide, According to the 2026 Marsh CFA Institute Global Pension IndexOctober 20 at 9:57 AM | marketscreener.comMMarsh & McLennan : Aging populations are straining retirement systems worldwideOctober 19 at 12:30 AM | marketscreener.comMSee More Headlines MRSH Stock Analysis - Frequently Asked Questions How have MRSH shares performed this year? Marsh & McLennan Companies' stock was trading at $161.65 on June 2, 2026. Since then, MRSH stock has increased by 17.9% and is now trading at $190.6130. How were Marsh & McLennan Companies' earnings last quarter? Marsh & McLennan Companies, Inc. (NYSE:MRSH) posted its earnings results on Thursday, October, 15th. The financial services provider reported $2.03 EPS for the quarter, beating the consensus estimate of $1.96 by $0.07. The business's quarterly revenue was up 8.1% on a year-over-year basis. Read the conference call transcript. Does Marsh & McLennan Companies have any subsidiaries? Marsh & McLennan Companies subsidiaries include these companies: Jardine Lloyd Thompson Group plc, Eustis Insurance & Benefits, Wortham Insurance & Risk Management, AD Corretora de Seguros, Bluefin, Jelf, Dawson Insurance, and others. Who are Marsh & McLennan Companies' major shareholders? Marsh & McLennan Companies' top institutional shareholders include Ninety One UK Ltd (1.18%), Robeco Institutional Asset Management B.V. (0.23%), Ninety One North America Inc. (0.08%) and Birch Hill Investment Advisors LLC (0.08%). Insiders that own company stock include John Q Doyle, Oscar Fanjul, Mark C Mcgivney, Nicholas Mark Studer, Dean Michael Klisura, Martin South, Paul Beswick, Lloyd M Yates, Martine Ferland, John Jude Jones and Stacy Mills. View institutional ownership trends. How do I buy shares of Marsh & McLennan Companies? Shares of MRSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Marsh & McLennan Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Marsh & McLennan Companies investors own include NVIDIA (NVDA), ExxonMobil (XOM), Broadcom (AVGO), American Express (AXP), Accenture (ACN), Visa (V) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 8/14 Dividend7/23/2026Ex-Dividend for 8/14 Dividend7/23/2026Dividend Payable8/14/2026Record date for 11/13 Dividend10/01/2026Ex-Dividend for 11/13 Dividend10/01/2026Last Earnings10/15/2026Today10/22/2026Dividend Payable11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 7 days, MRSH's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Insurance Sub-IndustryInsurance Brokers Current SymbolNYSE:MRSH Previous SymbolNYSE:MMC CIK62709 Webwww.corporate.marsh.com Phone(212) 345-5000Fax408-523-1390Employees95,000Year Founded1871Price Target and Rating Average Price Target for Marsh & McLennan Companies$204.42 High Price Target$226.00 Low Price Target$178.00 Potential Upside/Downside+7.2%Consensus RatingHold Rating Score (0-4)2.38 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)$8.36 Trailing P/E Ratio22.80 Forward P/E Ratio18.22 P/E Growth2.65Net Income$4.16 billion Net Margins14.20% Pretax Margin18.88% Return on Equity33.32% Return on Assets8.51% Debt Debt-to-Equity Ratio1.27 Current Ratio1.09 Quick Ratio1.09 Sales & Book Value Annual Sales$28.46 billion Price / Sales3.18 Cash Flow$11.64 per share Price / Cash Flow16.38 Book Value$31.36 per share Price / Book6.08Miscellaneous Outstanding Shares475,514,000Free Float473,707,000Market Cap$90.64 billion OptionableOptionable Beta0.59 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NYSE:MRSH) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marsh & McLennan Companies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marsh & McLennan Companies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
